UPS clinical trials subsidiary Marken has announced the opening of a kit building centre in Shanghai, the company’s third location in addition to Hamburg and Singapore.
The new 370 sq m facility is centrally located in the in the Pudong district and includes a processing area for patient sample collection kit assembly, a dedicated temperature-controlled storage area and office space.
The existing Shanghai logistics office will be co-located which allows the combined facility to import raw materials and distribute kits domestically throughout China, in addition to the movement of biological samples and clinical drug product.
Marken’s suite of services related to biological sample kit assembly and shipment includes procurement of all components and inventory management, kit assembly, distribution of kits to investigator sites or regional depots and to any destination around the world as well as storage and control of sampling kits built by central lab clients in any of Marken’s warehouses and delivery, when needed, to investigator sites.
Michael Culme-Seymour, VP Asia Pacific Asia Pacific Region, commented, “The opening of our new Shanghai facility allows us to provide more services to our customers in China. Shanghai is a strategically important gateway for China, as an important domestic hub for kit distribution but also as a key hub for distribution of clinical drugs and movement of biologic specimens. Adding the kit building capability to this location further strengthens our service offering in Shanghai and complements our operations in Beijing and Hong Kong. We now have 14 locations in the Asia Pacific region and we will continue to grow with our client’s needs.”
The world's largest collection of global supply chain intelligence